Turbocharge Your Vaccine Development

The industry’s response to COVID-19 has made it clear that vaccines made right – meaning “safe, efficacious and readily available” – will find a market, whether or not they’re in the headlines.

We’re not looking to introduce incremental change; instead, our modular approach to next-generation vaccine manufacturing is designed to integrate novel biological, analytical or process-related technologies that can leapfrog the industry forward.

As your clinical and commercial supply partner in vaccine discovery and development, we will be teaming you up with our experts in live viruses, viral vectors, oncolytic viruses and vectors, potency assays and virus-like particles (VLP) and antigen vaccines. Our capabilities extend to our industry-leading expression systems, which are already proving their mettle in vaccines directed at public health threats.